Should we still use iron dextran in hemodialysis patients?

被引：13

作者：

Hörl, WH ^{[1
]}

机构：

[1] Univ Hosp Vienna, Dept Med 3, Div Nephrol & Dialysis, Vienna, Austria

来源：

AMERICAN JOURNAL OF KIDNEY DISEASES | 2001年 / 37卷 / 04期

关键词：

D O I：

10.1053/ajkd.2001.23761

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：859 / 861

页数：3

相关论文

共 15 条

[1] AUERBACH M, 1988, J LAB CLIN MED, V111, P566
[2] Parenteral iron use in the management of anemia in end-stage renal disease patients
Bailie, GR
Johnson, CA
Mason, NA
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (01) : 1 - 12
[3] ESCHBACH JW, 2000, J AM SOC NEPHROL, V14, pA249
[4] Sodium ferric gluconate complex in sucrose: Safer intravenous iron therapy than iron dextrans
Faich, G
Strobos, J
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (03) : 464 - 470
[5] The safety of intravenous iron dextran in hemodialysis patients
Fishbane, S
Ungureanu, VD
Maesaka, JK
Kaupke, CJ
Lim, V
Wish, J
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (04) : 529 - 534
[6] Suspected iron dextran-related adverse drug events in hemodialysis patients
Fletes, R
Lazarus, JM
Gage, J
Chertow, GM
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (04) : 743 - 749
[7] INTRAVENOUS IRON DEXTRAN IN CLINICAL MEDICINE
HAMSTRA, RD
BLOCK, MH
SCHOCKET, AL
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 243 (17): : 1726 - 1731
[8] Hoigné R, 1998, SCHWEIZ MED WSCHR, V128, P528
[9] Jayakumar S, 2000, DIALYSIS TRANSPLANT, V29, P198
[10] Intravenous administration of iron in epoetin-treated haemodialysis patients - which drugs, which regimen?
Macdougall, IC
[J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (11) : 1743 - 1745